FDA Investigator David L Duncan
David L Duncan has conducted inspections on 8 sites in 1 countries as of 27 Nov 2000. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
8
Last Inspection Date:
27 Nov 2000
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with David L Duncan:
Amanda L Baskin,
Andrea D Swingle,
Angel S Johnson,
Benjamin J Smith,
Brian D Garthwaite,
Byungja E Marciante,
CDR Kimberly Y Martin,
Charles M Spyr,
Constantin Y Philopoulos,
Corrine M Carter,
Cynthia Jim, CSO,
Dawn C Olenjack,
Dr. Abhijit Raha, PhD,
Emest F Bizjak,
Etty Feller,
Jorge F Christian,
Joris Vanloco,
Kimberly A Dux,
L'oreal F Walker,
Larry K Austin,
Leigh Anne Myers,
Lynda L Lanning,
Meisha R Sampson,
Meisha Waters,
Michael Y Philopoulos,
Myra K Casey,
Neal D Singletary, PhD,
Patricia A Cochran,
Patricia H Dlugosz,
Ralph A Erickson,
Robert M Barbosa,
Sidney B Priesmeyer,
Susan P Bruederle,
Timothy C Schell
David L Duncan's Documents
Publish Date | Document Type | Title |
---|---|---|
December, 2000 | FDA 483 | Coulston Foundation - Form 483, 2000-12-08 |
August, 2000 | EIR | Labcorp Drug Development Inc. - EIR, 2000-08-30 |
August, 2000 | FDA 483 | Labcorp Drug Development Inc. - Form 483, 2000-08-30 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more